Does PACRITINIB Cause Neoplasm malignant? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Neoplasm malignant have been filed in association with PACRITINIB (Vonjo). This represents 0.4% of all adverse event reports for PACRITINIB.
11
Reports of Neoplasm malignant with PACRITINIB
0.4%
of all PACRITINIB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Neoplasm malignant From PACRITINIB?
Of the 11 reports, 2 (18.2%) resulted in death, 3 (27.3%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PACRITINIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does PACRITINIB Cause?
Diarrhoea (536)
Off label use (459)
Fatigue (320)
Product dose omission issue (279)
Death (261)
Nausea (246)
Platelet count decreased (237)
Haemoglobin decreased (171)
Asthenia (119)
Drug ineffective (98)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which PACRITINIB Alternatives Have Lower Neoplasm malignant Risk?
PACRITINIB vs PALBOCICLIB
PACRITINIB vs PALIPERIDONE
PACRITINIB vs PALIVIZUMAB
PACRITINIB vs PALONOSETRON
PACRITINIB vs PAMIDRONATE